Artificial Intelligence in the Diagnostic Market Report 2026

The artificial intelligence in the diagnostic market size has grown exponentially in recent years. It will grow from $5.97 billion in 2025 to $8.32 billion in 2026 at a compound annual growth rate (CAGR) of 39.5%. The growth in the historic period can be attributed to growing availability of medical imaging data, increasing digitization of healthcare records, rising shortage of skilled diagnosticians, early adoption of computer vision in radiology, expansion of healthcare IT infrastructure.

The artificial intelligence in the diagnostic market size is expected to see exponential growth in the next few years. It will grow to $31.31 billion in 2030 at a compound annual growth rate (CAGR) of 39.3%. The growth in the forecast period can be attributed to increasing demand for early disease detection, rising investments in ai-driven healthcare solutions, expansion of personalized medicine initiatives, growing integration of ai diagnostics in clinical workflows, increasing regulatory approvals for ai-based tools. Major trends in the forecast period include increasing adoption of AI-based diagnostic imaging tools, rising use of machine learning in clinical decision support, growing integration of ai with radiology and pathology workflows, expansion of predictive analytics in disease detection, enhanced focus on diagnostic accuracy and speed.

The increasing prevalence of chronic diseases is expected to drive the growth of AI in the diagnostics market in the coming years. Chronic diseases are long-lasting health conditions that endure over an extended period, often throughout a person’s lifetime. The integration of AI-based diagnostic tools in managing chronic diseases allows for early detection, predictive analysis, improved decision support systems, remote patient monitoring, cost savings, and personalized treatments by evaluating individual genetic profiles and disease progression. For example, in September 2023, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, there were 41 million deaths annually, accounting for 74% of non-communicable disease (NCD) or chronic disease-related deaths globally. Additionally, approximately 17.9 million deaths were due to cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2 million deaths from diabetes. Thus, the growing prevalence of chronic diseases is propelling the expansion of AI in the diagnostics market.

Major companies in the AI in diagnostics market are creating innovative technologies, such as AI modules, to strengthen their market position. An AI module is a self-contained software component that integrates specific AI functionalities or capabilities. For example, in March 2023, Qritive, a Singapore-based provider of AI-powered solutions, introduced QAi Prostate for prostate cancer diagnosis. QAi Prostate can accurately identify the most common type of prostate cancer, potentially enhancing diagnostic precision and lowering false positives. The tool assists pathologists in differentiating cancerous from non-cancerous tissue areas, supporting informed treatment decisions. QAi Prostate can also prioritize cases for faster diagnosis and reporting, improving efficiency and patient care.

In June 2024, Quest Diagnostics Inc., a US-based diagnostic information services provider, acquired assets of PathAI Diagnostics for an undisclosed sum. This acquisition enables Quest to strengthen its AI and digital pathology capabilities, particularly in cancer diagnostics, by integrating PathAI’s innovative technologies with its existing services. PathAI Inc., based in the US, specializes in advanced AI and digital pathology solutions for biopharmaceutical companies and pathology laboratories.

Major companies operating in the artificial intelligence in the diagnostic market are Siemens Healthineers, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Paige.AI Inc., HeartFlow Inc., Aidoc Medical Ltd., AliveCor Inc., Butterfly Network Inc., Imagen Technologies, Digital Diagnostics Inc., Brainomix Ltd., NovaSignal Corp., Enlitic Inc., Nano-X Imaging LTD., EchoNous Inc., Zebra Medical Vision Ltd., Aidence B.V., Neural Analytics Inc., IDx Technologies Inc., icometrix N.V., Vuno Inc.

North America was the largest region in the artificial intelligence in diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in the diagnostic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial intelligence in the diagnostic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the artificial intelligence in diagnostics market by increasing costs of imported imaging hardware, specialized processors, data servers, and advanced semiconductor components used in AI-enabled diagnostic systems. Hospitals and diagnostic centers in North America and Europe are most affected due to reliance on imported medical devices and computing infrastructure, while Asia-Pacific faces cost pressures on hardware-intensive deployments. These tariffs are increasing implementation costs and slowing system upgrades. However, they are also encouraging local manufacturing of diagnostic hardware, regional data center investments, and development of software-centric AI diagnostic platforms.

The artificial intelligence in the diagnostic market research report is one of a series of new reports that provides artificial intelligence in the diagnostic market statistics, including artificial intelligence in the diagnostic industry global market size, regional shares, competitors with a artificial intelligence in the diagnostic market share, detailed artificial intelligence in the diagnostic market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in the diagnostic industry. This artificial intelligence in the diagnostic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

AI in diagnostics involves the use of artificial intelligence (AI) technologies in medical diagnosis, utilizing advanced algorithms, machine learning, and data analysis methods to interpret medical data, images, and clinical information. The application of AI in diagnostics is designed to enhance the accuracy, speed, and efficiency of medical diagnoses.

The primary components of artificial intelligence in the diagnostic market include hardware, software, and services. Hardware refers to the physical parts of a computer system or other electronic devices. In diagnostics, AI hardware enhances processing power, enables real-time analysis, supports scalability, integrates with imaging devices, improves energy efficiency, strengthens security, ensures interoperability, allows customization, and boosts reliability, all of which together contribute to more effective and efficient diagnostic processes in healthcare. The key technologies include machine learning, natural language processing (NLP), context-aware computing, and computer vision, which are applied across various types of diagnostics such as radiology, pathology, cardiology, oncology, neurology, chest and lung, and other diagnostic areas.

The AI in diagnostics market consists of revenues earned by entities by providing services such as medical imaging analysis, disease prediction, and genomic sequencing analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. AI in diagnostics market also includes sales of AI-powered imaging systems, AI-driven pathology tools, and point-of-care diagnostic devices Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.